BOTHELL, WA, November 21, 2017 – FUJIFILM Sonosite Inc., specialists in developing cutting-edge, portable and point-of-care ultrasound solutions, will showcase its latest innovations at the 103rd annual meeting of the Radiological Society of North America (RSNA) at booth #4111 in the South Hall of McCormick Place in Chicago, Ill. Highlights from FUJIFILM Sonosite, Inc.’s portfolio include the Sonosite SII, Sonosite Edge II, and the Sonosite X-Porte.… [Read more]
BOTHELL, WA., November 21, 2016 (Booth #6713, North Building, Hall B) – FUJIFILM Sonosite Inc., specialists in developing cutting-edge ultrasound solutions and providing world-leading education to enable point-of-care visualisation access, will present its innovative portfolio of ultrasound solutions and highlight enhanced features and upgrades at the 102nd scientific assembly and annual meeting of the Radiological Society of North America (RSNA) held November 27 – December 2, 2016 at McCormick Centre in Chicago, Illinois.… [Read more]
Sonosite representatives joined Essex & Herts Air Ambulance (EHAAT) at Audley End House in Essex on the 25th June as the charity celebrated its 20th anniversary and unveiled its rebranded fleet – including the first public appearance of its recently purchased Augusta Westland AW169 helicopter – at an open day attended by 3,000 people.… [Read more]
Point-of-care ultrasound is used daily to help assess and treat patients in the emergency department.
London’s Chelsea and Westminster Hospital relies on point-of-care ultrasound to help assess and treat patients in its emergency department.… [Read more]
Point-of-care ultrasound plays an important role in the management of cardiac arrest.
Dr. Matthew Reed, an Emergency Medicine consultant at the Royal Infirmary of Edinburgh, explains why Sonosite ultrasound is used to help shorten the path to treatment for cardiac arrest victims in emergency and pre-hospital medicine.… [Read more]
Stamford, CT, February 1, 2017 (Booth #551) – FUJIFILM Medical Systems U.S.A., Inc., and FUJIFILM Sonosite, Inc. will present its comprehensive Synapse Enterprise Imaging product portfolio and its Sonosite iViz solution which integrates ultrasound with medical IT at the Healthcare Information and Management Systems Society (HIMSS) conference and exhibition held February 19-23, 2017 at Orange County Convention Centre in Orlando, Florida.… [Read more]
DUBAI, UAE, January 27, 2017 (Booth #S2.A30, Shake Sayeed Hall 2) – FUJIFILM Sonosite, specialists in developing cutting-edge ultrasound solutions and providing world-leading education to enable point-of-care visualisation access, will present its innovative portfolio of ultrasound solutions and highlight enhanced features and upgrades at Arab Health, the largest gathering of healthcare and trade professionals in the MENA region. Explore 4,400 of the world's leading healthcare companies coming in from 70 countries.… [Read more]
Toronto, Canada, January 12, 2017 – FUJIFILM VisualSonics Inc., a world leader in high-frequency ultrasound imaging systems and subsidiary of FUJIFILM Sonosite, Inc., today announced clearance from Health Canada for its Vevo® MD, the world’s first Ultra High-Frequency (UHF) clinical ultrasound system. The Vevo MD uniquely operates at much higher frequencies than any conventional ultrasound system currently available. This allows medical professionals to see sonograms with unparalleled image resolution—down to 30 micrometers.… [Read more]
A training exercise gives doctors and paramedics a feel for using point-of-care ultrasound in challenging environments… [Read more]
FUJIFILM is first to market with Ultra High Frequency Ultrasound System for Human Studies … [Read more]
Subcommittee on Primary Health and Aging to Explore Stemming More Than 1000 Preventable Deaths Each Day In The US Healthcare System
BOTHELL, WA, July 17, 2014 – FUJIFILM Sonosite Inc., the world leader and specialist in ultrasound performed at the point-of-care, applauds the US Senate Subcommittee on Primary Health and Aging for having a hearing to explore ways to stem the more than 1000 preventable patient deaths a day in the US healthcare system.
"This crisis needs to be addressed at the highest levels sooner rather than later, and we applaud the Senate for taking action," said Diku Mandavia, MD, Senior Vice President and Chief Medical Officer at FUJIFILM Sonosite. "The fact is that there are many tools and methods to prevent these deaths if adopted broadly across a hospital, including those to significantly reduce a major threat to patient safety –hospital-acquired conditions."
Hospital-acquired conditions (HACs) are complications that a patient may develop during a stay in a hospital or medical facility. To reduce this patient risk, many leading hospitals now mandate that their physicians adopt proven best practises. As an example, the Agency for Healthcare Research and Quality (AHRQ), as well as other medical groups recommend ultrasound-guided central line insertion for safer vascular access, based on overwhelming scientific evidence of its safety benefits.… [Read more]
Anil Amlani Appointed as New Chief Financial Officer
Effective January 5th
BOTHELL, WA– December 27, 2011– Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that Marcus Smith will resign as Senior Vice President, Chief Financial Officer and Treasurer, effective as of January 2, 2012 and will be leaving the company effective as of January 5, 2012. Anil Amlani, the current President and Chief Executive Officer of Sonosite’s VisualSonics subsidiary, has been appointed the new Chief Financial Officer of Sonosite, effective as of January 2, 2012.
“Anil is a seasoned executive and operator, and is an ideal successor to serve as Sonosite’s new CFO,” said Kevin M. Goodwin, Sonosite’s President and CEO. “For the past 20 years, he has successfully led businesses. He also has served as a Chief Financial Officer for public and non-public companies for 11 years in total. More recently, Anil has led our VisualSonics business before and after the acquisition in June 2010. His broad experience base and global perspective will position Sonosite well.”… [Read more]
Sponsored by Mt. Sinai Hospital, The Louis J. Acompora Memorial Foundation, and The Dominic A. Murray 21 Memorial Foundation
Free Screening October 22nd at Northport High School, Northport, New York
BOTHELL, WA - October 20, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for point-of-care medicine, proudly supports a community heart health screening to raise awareness and prevent sudden cardiac arrest in young adults.
Sponsored by the Louis J. Acompora Memorial Foundation, the Dominic A. Murray 21 Memorial Foundation and The Mount Sinai Hospital, the company will be providing physicians with its flagship M-Turbo ultrasound systems to perform a non-invasive cardiac ultrasound examination for the accurate evaluation of heart functionality, valve complications, and blood flow. Students between the ages of 14-24 are eligible for a free heart screening. The event will take place on October 22nd at the Northport High School in New York.… [Read more]
Revenues Hit $75.7 Million in the Quarter, Up 10%
Year-to-Date Revenues Reach $219.5 Million, Up 18%
Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern
BOTHELL, WA - October 25, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2011.
REVENUE
Revenues for the third quarter of 2011 were $75.7 million, rising 10% in comparison to $68.5 million in the third quarter of 2010.
Revenues for the nine months of 2011 were $219.5 million, compared to $186.1 million in 2010, an increase of 18%.
Overall order booking rates increased 16% in the quarter.
Foreign exchange contributed to a 2.1% favorable impact on third quarter results and a 2.8% favorable impact on the first nine months of 2011.
EBITDAS, EBITDA and OPERATING INCOME (EBIT)
Third Quarter:
For the quarter, EBITDAS includes non-recurring severance charges of $1.3 million from SG&A cost restructuring. Operating expense run rate savings are projected at $6.0 million for 2012, positioning the company for improved operating margins while launching new products and driving marketing initiatives in 2012.… [Read more]
BOTHELL, WA– November 15, 2011– Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Brian Noyes as the Vice President of Marketing for North America and South America.
“Brian is an excellent addition to Sonosite and we welcome him to the leadership team,” said Matthew Damron, Sonosite’s Global Chief Marketing Officer. “He is an accomplished leader with decades of experience in the medical device industry, a successful product launch track record, and a key factor in the growth of a $1 billion franchise at Johnson & Johnson. Brian is a very appealing candidate to further elevate our marketing execution to the next level with expertise that is essential as we prepare to unleash the most exciting products in our company’s history.”
“Sonosite is a company with tremendous growth opportunities and has an enviable position in the healthcare industry,” said Brian Noyes. “I’m joining the company at a very exciting time, and I look forward to capitalizing on the current marketing initiatives, driving product demand, and market expansion.”
… [Read more]
BOTHELL, WA– November 16, 2011– Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Richard Salzar as the Vice President and General Manager of Europe, Russia, and Africa.
“Richard is a strong leader with 30 years of experience in the healthcare industry,” said Kevin M. Goodwin, Sonosite’s President and CEO. “As we continue to position ourselves for growth in our international markets, Richard’s past success at the strategic and business level will further strengthen our ability to expand our international footprint. We anticipate optimally structuring our approach for improved execution and growth heading into 2012.”
“Sonosite is a unique company with a superior product line and long-term market opportunity,” said Richard Salzar. “I’m excited for the opportunity to join the company and I’m confident in my ability to leverage our current resources internationally and drive strong results in the coming years.”
… [Read more]
Company Received FDA 510(k) Clearance and is Now Shipping the EDGE System to US Customers
BOTHELL, WA - November 17, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has received FDA 510(k) clearance for its fifth generation, high performance EDGE™ ultrasound system. Designed with physician feedback in mind, the EDGE system reaches a new level of clinical performance and product design, arming physicians with a tool to deliver better, safer and improved patient care. The company is now commencing US customer deliveries. International deliveries are pending CE marking.
“The EDGE system is a tremendous product and we are excited to bring it to point-of-care medicine, said Kevin M. Goodwin, Sonosite’s President and CEO. “We are encouraged by the timely regulatory review process, which represents a collaborative effort by many. We look forward to adding this new tool to our core markets and providing physicians with the impact they have been asking for in healthcare delivery.”… [Read more]
New User Interface, Larger Screen Size and Exceptional Image Quality
BOTHELL, WA - December 21, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced it has received CE Marking (Conformité Européenne) in the European Union to market its next generation point-of-care product: EDGE™ ultrasound system. The EDGE system is currently available for sale in the U.S., following receipt of FDA Premarket Notification 510(k) clearance in November. Sonosite is now commencing international customer deliveries.
Engineered with new state-of-the-art technology, the EDGE ultrasound system takes point-of- care ultrasound to a whole new level of clinical performance and enables physicians to deliver the highest standard of patient care by driving greater efficiencies and the potential for improved outcomes in the hospital and office.
The EDGE ultrasound was formally introduced this fall at medical meetings and congresses in Europe and Australia. Physicians positively responded to the system:… [Read more]
Sonosite Participating in HIMSS Interoperability Showcase
BOTHELL, WA - April 2, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, will demonstrate its latest advances in connectivity and workflow integration technology on the Sonosite Turbo™ platform, during the Healthcare Information and Management System Society (HIMSS) 2009 Conference. The conference is being held in Chicago at McCormick Place, April 4-8th.
As a participant at the HIMSS' Interoperability Showcase, Sonosite will conduct live demonstrations on its M-Turbo® system to show how it communicates with multiple DICOM® compliant products to expedite workflow. Both the M-Turbo and S Series™ product lines support the following DICOM functions: Storage Commitment, Modality Performed Procedure Step (MPPS), Modality Work List (MWL), Print and Archive.… [Read more]
Sonosite Previews Preliminary First Quarter Revenue Results
BOTHELL, WA - April 6, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, today provided preliminary revenue results for the first quarter ended March 31, 2009. The company said worldwide revenue decreased by 1% - 2% in Q1 2009 compared to Q1 2008. On a constant currency basis, worldwide revenues grew 6% - 7% in the quarter, indicating a currency headwind of approximately 8%. US revenues grew approximately 4% year over year.
Continued slowing of US hospital capital spending drove a mid-teen percentage decline in Sonosite€™s US hospital revenues. This was offset by excellent growth in the company€™s US enterprise channel. International revenues decreased approximately 6% in the quarter, driven by the impact of a weaker dollar. On a constant currency basis the International sector was up approximately 8% in Q1 2009 on a year over year basis. These revenue estimates are preliminary. The company will report full financial results for the first quarter on April 27, 2009 after the close of market.
About Sonosite… [Read more]